Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say
May 16, 2023 at 12:35 PM EDT
The FDA is slated to make a decision on whether to approve Pfizer's shot in August, just before respiratory syncytial virus season in the fall.
